首页|CYB561D2基因在神经胶质瘤组织中的表达及临床意义

CYB561D2基因在神经胶质瘤组织中的表达及临床意义

扫码查看
目的 基于生物信息学分析,检测CYB561D2基因对于神经胶质瘤的患者的预后评估和意义。方法 选取2018年10月―2022年12月安庆市立医院神经外科接受手术治疗的神经胶质瘤患者的手术病理标本,共78例进行研究。手术路径过程中必须切除的正常脑组织作为对照组,共32例。采用荧光实时定量PCR和免疫组化分别对实验组与对照组的CYB561D2基因mRNA和蛋白浓度进行检测。结果 实验组患者的肿瘤组织中CYB561D2基因的表达程度均较高,肿瘤组织病理级别越高,具有越显著的表达,而对照组中并无明显的CYB561D2基因mRNA(x2=2。75)和蛋白表达(x2=2。19),P<0。05,有统计学差异。结论 神经胶质瘤中CYB561D2基因mRNA和蛋白表达明显增高,提示CYB561D2与神经胶质瘤的发生、发展及恶性程度有一定相关。
Expression of the CYB561D2 gene in glioma tissue and its clinical significance
Objective To investigate the expression and significance of the CYB561D2 gene in the prognostic evaluation of patients with glioma based on bioinformatics analysis.Methods A total of 78 pathological specimens were collected from the patients with glioma who received surgical treatment in Department of Neurosurgery,Anqing Municipal Hospital,from October 2018 to December 2022 and were enrolled as experimental group,and 32 specimens of normal brain tissue that must be removed during the surgical pathway were enrolled as control group.Quantitative real-time PCR and immunohistochemistry were used to measure the mRNA and protein expression levels of the CYB561D2 gene in both groups.Results The CYB561D2 gene was highly expressed in the glioma tissue of the patients in the experimental group,and the pathological grade of the tumor increased with the increase in the expression of the CYB561D2 gene,while there were no significant mRNA and protein expression levels of the CYB561D2 gene in the control group,with significant differences between the two groups(x2=2.75 and 2.19,P<0.05).Conclusion There are significant increases in the mRNA and protein expression levels of the CYB561D2 gene in glioma,suggesting that CYB561D2 is associated with the development,progression,and malignancy of glioma.

GliomaCYB561D2 geneSurgical resectionQuantitative real-time PCR

黄纯、周和平、查正江、朱克帅、宣兰兰、刘雅玲

展开 >

安徽省安庆市立医院神经外科,安徽 安庆 246003

安徽省安庆市立医院病理科,安徽 安庆 246003

神经胶质瘤 CYB561D2基因 手术切除 实时定量PCR

安徽省重点研究与开发计划

2022e07020052

2024

中风与神经疾病杂志
吉林大学

中风与神经疾病杂志

CSTPCD
影响因子:0.754
ISSN:1003-2754
年,卷(期):2024.41(2)
  • 21